Abstract:
Background: Based on pricing differences of the same medicine among manufacturers, this study
was designed to investigate the current oral anti-diabetic medication regimens for non-complicated
diabetic patients in the Mirpur region.
Methods: With the help of many Mirpur medical stores, doctors, and patients, the current study was
conducted over the course of 4 months with a random review of roughly 200 prescriptions. A
standard questionnaire with numerous questions was developed based on patient data (such as age,
gender, medical history, and prescriptions), doctor data (often prescribed drug, combination), and
pharmacy data (available alternatives, cost, and most popular brands).
Results: A statistical analysis of patient data suggests that 47.5% of patients are between the ages of
50 and 60 and that 92.5% of patients depend on oral anti-diabetic drugs. Their (54%) most common
consequences were hypertension-related. Doctors routinely provide metformin to patients with type
II diabetes mellitus, either alone or in fixed-dose combinations with glimmering or glazier, according to survey results. The cost of several different types of oral diabetes drugs varies widely, according
to cost analysis (75-87%). USV Pvt. Ltd. and Mankind Ltd.'s dominance over other pharmaceutical
companies may be seen in the annual revenue of these products in the regional Indian market.
Conclusions: This report will create better awareness among people for the availability of various
brands of same anti-diabetic drug and also motivate our physicians to prescribe the economic
products.
Keywords :Dhaka, Diabetes, oral antidiabetic drugs, Cost.
